< Back to situations

[ORGANIZATION]

DNB Bank ASA

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [DK]

Novo Nordisk pivots strategy to counter patent cliff

112 clusters · 548 sources · last updated

Latest: Novo Nordisk faces intense competition in obesity drug market

Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,

[QUIET] [BUSINESS] [DK] [NO] [FI]

European firms continue share buy-backs

15 clusters · 30 sources · last updated

Latest: DNB Bank and Ringkjøbing Landbobank update share buy-back status

Throughout July and August 2026, European companies continued a trend of share buy-backs, particularly within the Scandinavian financial and industrial sectors. In the banking and financial sector, several Nordic institu

Also covered in